PMDA Testing New System that Uses Electronic Medical Information to Help Assess Post-Marketing Drug Risk

The Pharmaceuticals and Medical Devices Agency (PMDA) has started a “MIHARI (Medical Information for Risk Assessment Initiative) Project” to test new post-marketing safety measures. The project is testing a new system for secondary use of electronic medical information such as...read more